3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
119
OTHER
91
NIH
20
NETWORK
3
UNKNOWN
1
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Melanoma
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Advanced Cancer
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Lymphoma
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Advanced Tumor of Digestive Tract or Urinary System
1
Adenocarcinoma
1
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
UNKNOWN
×
Urinary Bladder Neoplasms
×
Clear all
NCT02346955
2020-08-27
MK-6018-001
KitovPharma
Phase 1
Terminated
27 enrolled